Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes

The incidence of diabetes mellitus (DM) is rising. DM is a risk factor for developing left ventricular (LV) dysfunction and adverse cardiovascular outcomes. Insulin, commonly used to treat DM, is associated with further worsening of such outcomes. Yet, the pathophysiology of the adverse properties o...

Full description

Bibliographic Details
Main Authors: Fadi W. Adel, Ye Zheng, Siu-Hin Wan, Christie Greason, Shuchong Pan, Syed Ameenuddin, Horng H. Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2022.890907/full
_version_ 1828342941158998016
author Fadi W. Adel
Ye Zheng
Siu-Hin Wan
Christie Greason
Shuchong Pan
Syed Ameenuddin
Horng H. Chen
author_facet Fadi W. Adel
Ye Zheng
Siu-Hin Wan
Christie Greason
Shuchong Pan
Syed Ameenuddin
Horng H. Chen
author_sort Fadi W. Adel
collection DOAJ
description The incidence of diabetes mellitus (DM) is rising. DM is a risk factor for developing left ventricular (LV) dysfunction and adverse cardiovascular outcomes. Insulin, commonly used to treat DM, is associated with further worsening of such outcomes. Yet, the pathophysiology of the adverse properties of insulin on the heart remains poorly defined. Therefore, the objective of this study was to determine the biological effects of insulin on the heart in DM, which we tested in vivo in a diabetic rat model and in vitro on human cardiomyocytes and fibroblasts. Male Wistar rats were divided into 3 groups: controls (n = 17), untreated diabetics (UDM, n = 15), and insulin-treated diabetics (IDM, n = 9). Diabetes was induced with Streptozotocin. Insulin pumps in IDM and saline pumps in UDM and controls were implanted for 4 weeks before tissue collection. Separately, cultures of human cardiomyocytes (AC16) and human cardiac fibroblasts (HCF) were treated with insulin to assess apoptosis and fibrosis, respectively. In rats, insulin partially rescued the DM-associated weight loss while fully restoring euglycemia. However, IDM had 2 × the rate of LV fibrosis (p < 0.0001) compared to UDM, and triple the rate of cardiomyocyte apoptosis compared to controls (p < 0.05). Similarly, in vitro, insulin triggered apoptosis in a dose-dependent fashion in AC16 cells, and it increased fibrosis and upregulated SMAD2 in HCF to levels comparable to Transforming Growth Factor Beta 1. Therefore, we conclude that insulin therapy is associated with increased cardiomyocyte apoptosis and myocardial interstitial fibrosis. Longer studies are needed to explore the long-term effects of insulin on cardiac structure and function.
first_indexed 2024-04-13T23:36:03Z
format Article
id doaj.art-3d8a6afca12347048bc37c7697bae807
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-04-13T23:36:03Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-3d8a6afca12347048bc37c7697bae8072022-12-22T02:24:44ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2022-04-011310.3389/fphys.2022.890907890907Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental DiabetesFadi W. Adel0Ye Zheng1Siu-Hin Wan2Christie Greason3Shuchong Pan4Syed Ameenuddin5Horng H. Chen6Cardiorenal Research Laboratory, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United StatesCardiorenal Research Laboratory, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United StatesMinneapolis Heart Institute, United Hospital, Saint Paul, MN, United StatesCollege of Biological Sciences, University of Minnesota, Minneapolis, MN, United StatesCardiorenal Research Laboratory, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United StatesCardiorenal Research Laboratory, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United StatesCardiorenal Research Laboratory, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United StatesThe incidence of diabetes mellitus (DM) is rising. DM is a risk factor for developing left ventricular (LV) dysfunction and adverse cardiovascular outcomes. Insulin, commonly used to treat DM, is associated with further worsening of such outcomes. Yet, the pathophysiology of the adverse properties of insulin on the heart remains poorly defined. Therefore, the objective of this study was to determine the biological effects of insulin on the heart in DM, which we tested in vivo in a diabetic rat model and in vitro on human cardiomyocytes and fibroblasts. Male Wistar rats were divided into 3 groups: controls (n = 17), untreated diabetics (UDM, n = 15), and insulin-treated diabetics (IDM, n = 9). Diabetes was induced with Streptozotocin. Insulin pumps in IDM and saline pumps in UDM and controls were implanted for 4 weeks before tissue collection. Separately, cultures of human cardiomyocytes (AC16) and human cardiac fibroblasts (HCF) were treated with insulin to assess apoptosis and fibrosis, respectively. In rats, insulin partially rescued the DM-associated weight loss while fully restoring euglycemia. However, IDM had 2 × the rate of LV fibrosis (p < 0.0001) compared to UDM, and triple the rate of cardiomyocyte apoptosis compared to controls (p < 0.05). Similarly, in vitro, insulin triggered apoptosis in a dose-dependent fashion in AC16 cells, and it increased fibrosis and upregulated SMAD2 in HCF to levels comparable to Transforming Growth Factor Beta 1. Therefore, we conclude that insulin therapy is associated with increased cardiomyocyte apoptosis and myocardial interstitial fibrosis. Longer studies are needed to explore the long-term effects of insulin on cardiac structure and function.https://www.frontiersin.org/articles/10.3389/fphys.2022.890907/fullinsulindiabetesfibrosisapoptosisrat model
spellingShingle Fadi W. Adel
Ye Zheng
Siu-Hin Wan
Christie Greason
Shuchong Pan
Syed Ameenuddin
Horng H. Chen
Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes
Frontiers in Physiology
insulin
diabetes
fibrosis
apoptosis
rat model
title Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes
title_full Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes
title_fullStr Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes
title_full_unstemmed Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes
title_short Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes
title_sort insulin therapy is associated with increased myocardial interstitial fibrosis and cardiomyocyte apoptosis in a rodent model of experimental diabetes
topic insulin
diabetes
fibrosis
apoptosis
rat model
url https://www.frontiersin.org/articles/10.3389/fphys.2022.890907/full
work_keys_str_mv AT fadiwadel insulintherapyisassociatedwithincreasedmyocardialinterstitialfibrosisandcardiomyocyteapoptosisinarodentmodelofexperimentaldiabetes
AT yezheng insulintherapyisassociatedwithincreasedmyocardialinterstitialfibrosisandcardiomyocyteapoptosisinarodentmodelofexperimentaldiabetes
AT siuhinwan insulintherapyisassociatedwithincreasedmyocardialinterstitialfibrosisandcardiomyocyteapoptosisinarodentmodelofexperimentaldiabetes
AT christiegreason insulintherapyisassociatedwithincreasedmyocardialinterstitialfibrosisandcardiomyocyteapoptosisinarodentmodelofexperimentaldiabetes
AT shuchongpan insulintherapyisassociatedwithincreasedmyocardialinterstitialfibrosisandcardiomyocyteapoptosisinarodentmodelofexperimentaldiabetes
AT syedameenuddin insulintherapyisassociatedwithincreasedmyocardialinterstitialfibrosisandcardiomyocyteapoptosisinarodentmodelofexperimentaldiabetes
AT hornghchen insulintherapyisassociatedwithincreasedmyocardialinterstitialfibrosisandcardiomyocyteapoptosisinarodentmodelofexperimentaldiabetes